Nuveen
JAZZ icon

Nuveen’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nuveen’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,100
Closed -$3K – 3324
2020
Q2 		$3K Buy
+28,100
New +$3.11M ﹤0.01% 3242
2020
Q1 		– Sell
-28,100
Closed -$4K – 3231
2019
Q4 		$4K Buy
+28,100
New +$3.82M ﹤0.01% 3206

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Nuveen's JAZZ Position: Q2 2026 in Review

Nuveen increased its Jazz Pharmaceuticals (JAZZ) stake by 5.6% in Q2 2026, buying an estimated $4.22M and bringing the position to 365,405 shares worth $88.1M. The position accounts for 0.02% of the portfolio, ranked #473.

Nuveen first reported a position in JAZZ in Q2 2013 and has held it in 51 quarters since. The position peaked at $274M in Q2 2019. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Nuveen held 365,405 shares of Jazz Pharmaceuticals worth $88.1M as of Q2 2026.
  • Nuveen bought 19,257 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.22M.
  • Jazz Pharmaceuticals made up 0.02% of Nuveen's portfolio in Q2 2026, its #473 holding.
  • Nuveen first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Nuveen's Jazz Pharmaceuticals position peaked at $274M in Q2 2019.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.